ACNOF Aerocrine AB (publ), together with its subs

ACNOF Aerocrine AB (publ), together with its subsidiaries, develops and sells medical technology products for use in the treatment and care of patients with inflammatory airway diseases. The company offers exhaled nitric oxide (NO) monitoring devices for research and clinical applications. Its products comprise NIOX MINO, a hand-held device for the diagnosis and management of asthma and other inflammatory airway conditions to smaller clinics, healthcare centers, and hospitals; and NIOX Flex, a device for measuring exhaled NO. The company has a partnership with Panasonic Health Care Ltd for the design, prototyping, and production launch of products for physicians and home use. Aerocrine AB (publ) sells its products primarily in Europe, the United States, rest of North America, Asia, and rest of Oceania. The company was founded in 1997 and is headquartered in Solna, Sweden.